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C E L L  B I O L O G Y
Oncogenic RAS instructs morphological transformation 
of human epithelia via differential tissue mechanics
Agata Nyga1,2, Jose J. Muñoz3,4,5, Suze Dercksen6, Giulia Fornabaio1,7, Marina Uroz1,8,  
Xavier Trepat1,9,10,11, Buzz Baum2,12, Helen K. Matthews12, Vito Conte1,6,13*
The loss of epithelial homeostasis and the disruption of normal tissue morphology are hallmarks of tumor develop-
ment. Here, we ask how the uniform activation oncogene RAS affects the morphology and tissue mechanics in 
a normal epithelium. We found that inducible induction of HRAS in confined epithelial monolayers on soft 
substrates drives a morphological transformation of a 2D monolayer into a compact 3D cell aggregate. This trans-
formation was initiated by the loss of monolayer integrity and formation of two distinct cell layers with differential 
cell-cell junctions, cell-substrate adhesion, and tensional states. Computational modeling revealed how adhesion 
and active peripheral tension induces inherent mechanical instability in the system, which drives the 2D-to-3D 
morphological transformation. Consistent with this, removal of epithelial tension through the inhibition of acto-
myosin contractility halted the process. These findings reveal the mechanisms by which oncogene activation 
within an epithelium can induce mechanical instability to drive morphological tissue transformation.
INTRODUCTION
Epithelia are layered tissues, which provide separation between the 
inside and external environment. To perform this barrier function, 
the organization of the epithelial tissues must be maintained as 
individual cells proliferate and die. Maintenance of epithelial 
homeostasis requires the dynamic regulation of cell proliferation, cell 
packing (1), and cell extrusion (2–4), the maintenance of a sheet-like 
morphology through the tight cell-cell association through intercellular 
junctions (5) and stable anchoring between cells and the extracellular 
matrix (ECM) (6).
Loss of homeostasis and the subsequent breakdown of tissue 
organization is a hallmark of epithelial-derived cancers, where 
oncogene activation results in the loss of carefully balanced control 
mechanisms. RAS oncogenes (HRAS, NRAS, and KRAS) are one of 
the most common mutated genes in human cancer with RAS activa-
tion occurring in around 30% of all cancers (7, 8). RAS activation 
affects individual cell mechanics through alterations in actomyosin 
contractility (9–12). At the tissue scale, RAS disrupts epithelial 
homeostasis, resulting in loss of tissue polarity (13) and barrier 
function (14). Normal epithelia act as a barrier against single RAS 
cells or RAS cell clusters through their extrusion or delamination 
(15–21). The extrusion of RAS cells has been shown to be driven by 
actomyosin-dependent forces acting at the interface between normal 
and transformed cells (18,  20) and can be affected by tissue-level 
mechanical forces (17). Larger clusters of RAS cells can separate 
from normal neighbors (22, 23) to form cysts (19), outgrowths, or 
invaginations (24). Despite these morphological and mechanical roles 
for RAS, it is still not clear how cell and tissue mechanics mediate 
RAS signaling to morph epithelia independently of interactions 
between nontransformed and RAS-transformed cells.
Here, we investigated how the uniform activation of oncogenic 
RAS alters the morphology and mechanics of an epithelial mono-
layer and their cross-talk. In confined epithelial monolayers grown 
on soft physiological substrates, oncogenic HRAS expression was 
sufficient to transform the epithelial monolayer into a multilayered 
structure characterized by layer-specific differences in cell-cell 
contractility and cell-matrix adhesions. Furthermore, the increase 
in peripheral tension induced by oncogenic HRAS destabilized tissue 
mechanics to set the epithelia on a path to a three-dimensional (3D) 
morphological transformation.
RESULTS
Oncogenic RAS expression induces the active dewetting 
of confined MCF10A monolayers
To systematically study the effects of RAS activation on epithelial 
morphology and mechanics live (Fig. 1A), we conditionally activated 
oncogenic HRAS in nontransformed MCF10A human epithelial cells, 
MCF10A/ER:HRASV12 (25). We modeled the physiological stiffness 
of basement membrane and underlying ECM by plating cells on 
soft polyacrylamide (PAA) gel substrates with a stiffness of 12 kPa 
(26, 27). We coated substrates with rat tail collagen type I micropat-
terned in circular shapes of 400 m in diameter (Fig. 1A). Epithelial 
cells were grown on these soft circular micropatterned substrates 
for 24 hours. At the time point t = 0 hours, the expression of HRAS.
V12 was induced in the epithelial monolayers through the addition 
of 4-hydroxytamoxifen (4-OHT) (HRAS-transformed epithelia). 
The vehicle control [dimethyl sulfoxide (DMSO)] was added to the 
remaining cellular monolayers as a control (nontransformed epithelia). 
Unexpectedly, we found that HRAS activation (Fig. 1B) was suffi-
cient to transform the 2D epithelial monolayer into a 3D mass 
(Fig. 1, C and D, and fig. S1).
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Fig. 1. Morphological characterization of normal and HRAS-transformed MCF10A tissues. (A) Schematic of the experimental setup. (B) HRAS induction confirmed by 
increase in phosphorylation of mitogen-activated protein kinase (MAPK) (ERK1/2) shown in representative Western blots. (C) Phase contrast time-lapse of selected 
nontransformed (control) and HRAS-transformed MCF10A monolayers (imaging starts at t = −4 hours, and HRAS activation is induced at t = 0 hours; scale bars, 200 m). 
(D) Contours of epithelia shown in (C) (time progresses with blue, red, green, and yellow colors). (E) Time evolution of the surface area of the epithelia’s footprint on the 
substate matrix (epithelial domain). (F) Time evolution of the major and minor diameters of the epithelia domain in the case of nontransformed and HRAS-transformed 
epithelia. (G) Cell number in HRAS-transformed epithelia at 12 hours after induction [start of area decline, (E)] compared to nontransformed epithelia at 12, 24, and 
44 hours. Kruskal-Wallis test + Dunn’s multiple comparisons test. (H) Time evolution of the epithelial domain’s aspect ratio (i.e. major axis divided by minor axis of the 
epithelial domain). (I) Time evolution of the epithelial domain’s circularity. (E to I) Statistics over 15 nontransformed epithelia and 16 HRAS-transformed epithelia 
from at least four independent experiment repeats. Each epithelium was imaged for at least 50 hours. (J) Time evolution of the surface area of the nontransformed (n = 7) 
and HRAS-transformed (n = 8) epithelia domains during cell cycle arrest (9 M RO-3306). (E, F, and H to J) Time evolution graphs represent means ± SEM of medians at each 
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To define the path of this 2D-to-3D cellular transformation, we 
monitored the process via a set of objective morphological (Fig. 1) 
and mechanical measures (Fig. 2). Specifically, we quantified the 
area (Fig. 1E), aspect ratio (Fig. 1H), circularity (Fig. 1I), and traction 
forces (Fig. 2) for each cellular island.
Morphological analyses revealed differences between RAS and 
control epithelial monolayers beginning ~4 hours after HRAS 
induction. Whereas control monolayers remained flat and main-
tained a near-constant area throughout the time window of our 
analysis, from 4 hours after oncogenic HRAS induction, monolayer 
islands exhibited a slow decrease in area. This decrease in circu-
lar area continued in an approximately symmetric fashion up until 
24 hours after HRAS induction, after which the symmetry of 







Fig. 2. Mechanical characterization of normal and HRAS-transformed MCF10A tissues. Overlays of traction-force vectors (A and B) and traction-force magnitude 
maps (D and E) on phase contrast images of confined MCF10A epithelia. (A and D) Representative nontransformed epithelium at t = 19 hours. (B and E) Representative 
HRAS-transformed epithelium at t = 45 hours. (C) Schematic representing the whole epithelial domain along with its outer and inner subdomains. (F and G) Kymographs 
of the radial (perpendicular) component of the traction field T⊥: (F) for a representative nontransformed MCF10A epithelium and (G) for a representative HRAS-transformed 
MCF10A epithelium. White lines represent the average evolution of the edge of the island in time, the center of the island colocalizing with the bottom of the graph. 
A negative component T⊥ (red) means that the corresponding traction-force vector is oriented toward the exterior of the epithelial domain’s edge, whereas a positive 
component T⊥ (green) is indicative of traction-force orientation toward the interior of the epithelial domain’s edge. (H to M) Time evolution of magnitudes and components 
of the traction-force field in the whole epithelial domain (blue) and in the inner (orange) and outer (green) epithelial subdomains. (H and K) Time evolution of the average 
traction field ± magnitude for (H) nontransformed epithelia and (K) HRAS-transformed epithelia. Time evolution of the average traction force components: (I and L) perpen-
dicular to the epithelial domain’s edge (T⊥) for (I) nontransformed and (L) HRAS-transformed epithelia and (J and M) tangential to the epithelial domain’s edge (T∥) for (J) 
nontransformed and (M) HRAS-transformed epithelia. (H to M) Statistics over 15 nontransformed epithelia and 16 HRAS-transformed epithelia from at least four independent 
experiment repeats. Each epithelium was imaged for at least 50 hours. Median over each epithelial domain at each time point of its evolution. Time evolution graphs 
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At this point, HRAS-transformed monolayers underwent a loss of 
circularity and an increase in aspect ratio (Fig. 1, H and I). This was 
followed by a rapid transition as the 2D HRAS-transformed epithe-
lium started to morph into a 3D cell mass (fig. S1). None of these 
changes were seen in control nontransformed monolayers. To 
study the impact of cell proliferation induced by HRAS on this be-
havior, we compared the number of cells in HRAS-transformed 
epithelia at 12 hours (when the cellular island is still a monolayer) 
with the number of cells in nontransformed epithelia over the span 
of the time window of our analysis. By 12 hours, the area of 
RAS-transformed monolayers had started decreasing substantially 
compared to pretransformation levels. By contrast, the increase 
in number of cells in nontransformed epithelia was not accom-
panied by a substantial decrease in surface area (Fig. 1, E and G). In 
addition and contrary to previous reports (28, 29), inhibiting cell pro-
liferation (cell cycle arrest via RO-3306 treatment; Fig. 1J) did not pre-
vent 2D RAS-transformed monolayers morphing into a 3D cell mass 
(Fig. 1J). Together, these results indicated that cell proliferation did 
not drive the 2D-to-3D morphological transition undergone by 
HRAS-transformed monolayers.
Mechanical analyses carried out using traction force microscopy 
(30) showed that elevated traction forces were mainly localized at 
the periphery of epithelial islands. This was the case for both 
nontransformed and HRAS-transformed monolayers (Fig. 2, A, 
D, H, and K). In both cases, the elastic strain energy transferred by 
the epithelium to the underlying substrate followed a similar trend 
(fig. S2). The accumulation of traction force at the periphery of 
circular epithelial islands is in keeping with previous theoretical 
work (31, 32) and experimental data from studies of human colon 
carcinoma cells (HCT-8) (33) and on confined circular monolayers 
of canine kidney cells (MDCK) (34, 35).
Traction forces tended to be more ordered at the epithelium’s 
periphery (Fig. 2, A and B). To better understand this, we decom-
posed the traction field along the directions normal and tangential 
to the epithelial domain’s edge (fig. S3) and computed the net 
radial (T⊥) and net tangential (T∥) traction force components as a 
function of time in the whole epithelial domain and in the central 
(inner) and peripheral (outer) domains (Fig. 2C). These time trends 
(Fig. 2, I, J, L, and M) confirmed that the net physical interactions 
at the interface between epithelia and substrate developed along 
the direction perpendicular to the epithelium’s edge for both 
nontransformed and HRAS-transformed epithelia throughout 
the analysis.
To average out spatial-temporal fluctuations of the traction 
force field and better visualize reproducible force patterns, we 
averaged the net radial traction components T⊥ in space along lines 
concentric to the edge of the island. Upon displaying these space 
averages as a function of distance from the epithelial domain’s edge, 
we obtained kymographs of the net radial traction component T⊥ 
for both nontransformed (Fig. 2F) and HRAS-transformed MCF10A 
epithelia (Fig. 2G). Kymographs confirm that it is the intense net 
radial traction components that concentrate mainly at the pe-
riphery of both nontransformed and HRAS-transformed epithelia 
throughout the experiment. By analyzing the stress distribution 
within the epithelial domain through monolayer stress microscopy 
(Materials and Methods) (30), we further showed that nontrans-
formed epithelia successfully establish and maintain epithelial 
homeostasis by means of long-range transmission of physical forces 
throughout the monolayer from opposite edges of the epithelium, 
which results in tension accumulating throughout the epithelial 
island (fig. S4).
The traction force analysis also revealed a characteristic two-
phase oscillation in the traction field during the course of our 
analysis (Fig. 2K) that was specific to HRAS-transformed epithelia. 
Forces first decreased over a period of approximately 8 hours and 
then increased by 24 hours following HRAS induction (Fig. 2, 
K  and  L). Epithelial islands then underwent an abrupt 2D-to-3D 
morphological transformation (Fig.  1B and fig. S1), which was 
accompanied by rapid morphological (Fig. 1) and mechanical (Fig. 2) 
changes and is reminiscent of previously described cellular process 
of active dewetting (36), in which the tissue retraction is driven by a 
monotonical increase in tension and in cell-matrix traction forces 
oriented toward the center of the circular monolayer. These behaviors 
were not peculiar to HRAS, as the overexpression of KRASV12 led to 
similar results. Upon KRASV12 activation, confined circular mono-
layers of inducible MCF10A/ER:KRASV12 cells followed a similar 
morphomechanical fate (fig. S5). The reproducible order of events 
observed following oncogenic RAS induction led us to hypothesize 
that oncogenic RASV12 primes epithelia for dewetting in the first 
24 hours by inducing structural and mechanical changes within the 
monolayer while it is still morphologically flat.
Oncogenic HRAS expression triggers the bilayering 
of confined MCF10A monolayers
To test this idea, we analyzed cellular organization in the z plane 
orthogonal to the underlying substrate at early stages following RAS 
induction. This revealed early changes in both nuclear and mono-
layer height (Fig. 3, A and B). Thus, within 24 hours of oncogene 
activation, RAS-transformed epithelia became an average of 25% 
thicker than nontransformed ones (Fig. 3A and fig. S6). This was 
accompanied by an increase in cell packing that was markedly higher 
in the confined RAS-transformed monolayers, leading to the ob-
served decrease in the area of individual cells (Fig. 3C). The heights 
of nuclei in both nontransformed and RAS-transformed MCF10A 
monolayers were uniform up to 8 hours from oncogene activation 
(Fig. 3B). Then, between 8 and 24 hours, the heights of nuclei of 
RAS-transformed epithelia showed greater heterogeneity (37) as the 
RAS-expressing epithelium (but not the control) became multilayered 
(Fig. 3D). Notably, confocal microscopy of these epithelia revealed 
the segregation of confined RAS-transformed epithelia into two 
discrete cellular layers with very distinct organizations (Fig. 3, 
D and E). The cells forming the top layer of RAS-transformed 
epithelia were flatter and more spread out than those in the bottom 
layer (Fig. 3E), as measured by a 1.5-fold increase in the perimeter 
of cells (Fig. 3G) and a threefold increase in average cell area 
(Fig. 3F), without a concomitant change in aspect ratio (Fig. 3H). 
We next turned our focus on the cellular alterations that could 
cause the bilayering.
Oncogenic HRAS expression induces layer-specific 
differences in cell-cell contractility and cell-matrix 
adhesions of the MCF10A bilayers
Stable RAS transformation has been shown to disrupt cadherins to 
promote cell invasion (38–40). Therefore, we hypothesized that the 
bilayering induced by oncogenic RAS expression might also be 
caused by disruption to cell-cell junctions. Nontransformed MCF10A 
cells constitutively expressed E-cadherin and, thus, exhibited uniform 
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expression did not change during RAS activation (Fig. 4A). Never-
theless, we observed differences in the localization of E-cadherin in 
the two layers of the developing bilayer (Fig.  4B). Cells in the 
bottom layer tended to have relatively low levels of E-cadherin at 
cell-cell junctions, while junctional E-cadherin levels remained similar 
to those before RAS activation in the top layer (Fig. 4C). In addition, 
the ratio of junctional to cytoplasmic E-cadherin was decreased 
in the bottom layer (Fig. 4D), suggestive of a redistribution of the 
protein away from junctions to cytoplasm. RAS-induced change in 
E-cadherin localization in the bottom layer was paralleled by a 
reduction of cell-matrix adhesion between the epithelial cells of this 
layer and the hydrogel substrate, as shown by a specific decrease in 
the expression of the collagen receptor integrin 1 (fig. S7, A to C). 
There was no difference in the expression of integrin 3 or 6 
(fig. S7, D to F).
The structural alterations occurring in RAS-transformed epithelia 
at the level of cell-cell junctions (Fig. 4, A to E) and cell-matrix 
adhesions (Fig. 4, E to G) correlated with the initial decrease observed 
in traction forces transferred by the epithelium to the substrate 
matrix during the first ~8 hours of oncogene induction (Fig. 2K). 
However, traction forces recovered to pretransformation levels by 
24 hours of RAS transformation (Fig. 2K), while adhesion to the 
substrate kept decreasing (Fig. 4, E to G). Since tension, measured 
by increase in ROCK (Rho-associated kinases), RhoA, and pMLC2 
(phospho-myosin light chain 2), was previously associated with 
abnormal morphology of 3D malignant epithelial acini (29), we 
tested whether RAS-driven alterations to epithelial structure are 
reflected in changes in epithelial tension [driven by the contractile 
cellular actomyosin cortex (41, 42)] by looking at the distribution of key 






Fig. 3. Oncogenic HRAS-expression induces the bilayering of MCF10A monolayers. (A to C) Measurements of epithelial monolayer features at selected time points 
for both nontransformed and HRAS-transformed epithelia: (A) tissue height, (B) nucleus height, and (C) cell area (in m2). Kruskal-Wallis statistic test with Dunn’s multiple 
comparison test. (D) Representative confocal images of nontransformed monolayer (top) and HRAS-transformed bilayer (bottom) at t = 24 hours from oncogene induction. 
Focal planes are orthogonal to the substrate matrix (z axis). Actin is labeled in gray, and nuclei are labeled in blue. Scale bars, 15 m. (E) Representative confocal 
image of nontransformed monolayer and HRAS-transformed bilayer. Focal plane crosses the tissue parallel to the substrate matrix. Actin is labeled in shades of gray, and 
nuclei are labeled in blue. Scale bars, 15 m. (F to H) Quantification of cell features in the top and bottom layers of HRAS-transformed bilayers: (F) cell surface area, (G) cell 
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and RAS-transformed epithelia. While nontransformed epithelia 
show uniform distribution of F-actin and pMLC2 (Fig. 5, A to C), 
oncogenic RAS expression induced a gradient in the distribution of 
F-actin and pMLC2 throughout the bilayer within 24 hours of on-
cogene activation (Fig. 5, D to H). F-actin and pMLC2 fluorescent 
intensity were higher at the periphery of the bottom layer of 
RAS-transformed bilayers (Fig. 5, D to F). This fluorescent intensity 
was lower and more heterogeneously distributed throughout the 
top layer (Fig. 5, G and H), although spots of highly increased 
pMLC2 expression were visible at the periphery and in the middle 
of the top layer of RAS-transformed bilayers (Fig. 5G). Thus, these 
results show that while nontransformed monolayers retained a 
uniform homogenous state of tension (fig. S4) and organization 
(Figs. 1 and 2) as they grew under these conditions, oncogenic RAS 
expression led to the establishment of a tension gradient that 
destabilizes the epithelium within 24 hours, leading to a radial 
contraction (Fig. 1, E, F, H, and I) and the formation of multiple cell 
layers with very different properties (Fig. 2). To test whether this 
idea is physically plausible, we developed a simple computational 
model of circular cellular monolayer.
Oncogenic HRAS expression makes confined monolayers 
mechanically instable
The RAS-transformed circular epithelial bilayers were modeled in 
silico as a 2D continuum elastic disk having finite thickness in 
approximation of plain stress (Fig. 6A and Materials and Methods). 
The epithelial disk was mechanically coupled to the substrate 
matrix at discrete focal contact points (Fig. 6B). The effects of RAS 
induction were modeled on the basis of experimental data (Materials 
and Methods). The model emulated the dynamics of discrete focal 
contact points between cells of the monolayer and the substrate 
matrix by means of a viscoelastic solid friction law (44). Decreased 
adhesion between RAS-transformed bilayers and the underlying 
substrate matrix (Fig. 4, F to G) was modeled as a uniform value of 
solid friction that decreases in time (Fig. 6F and Materials and Methods). 
Increased cellular tension at the periphery of RAS-transformed bilayers, 
as observed in the experimental distributions of F-actin and pMLC2 
(Fig.  5,  C  and  F), was modeled as an increase in contractility 
(Fig. 6G) at the epithelial disk’s periphery (Fig. 6G). The increase in 
tension intensity was made proportional to the relative fluorescence 
intensities of pMLC2 (Fig.  5C and Materials and Methods). The 
finite element method was used to numerically resolve the bilayer’s 
deformations generated by active contractile cellular forces against 
friction of the in silico epithelial disk with the substrate (Fig. 6, 
C and D, and Materials and Methods). We then computed the 
profiles of the area of the epithelial disk and the traction force trans-
mitted to the substrate (Fig. 6, H to M) as a function of cellular 
contractility (Fig. 6G) and/or cell-matrix adhesion (Fig. 6F).
Our simulations confirmed that an initial decrease in the adhe-
sion between the epithelial disk and the underlying matrix can lead 
to a decrease in average traction force magnitude (Fig. 6I) and early 
contraction of the epithelium (Fig. 6H). However, despite cell-matrix 
adhesion further decreasing, our simulations showed that a pro-
gressive increase in epithelial tension led to the recovery of traction 
force magnitude to pretransformation levels (Fig.  6I) and further 





Fig. 4. Oncogenic HRAS expression alters the expression of E-cadherin. (A) Western blot showing E-cadherin expression in nontransformed (control) and HRAS-transformed 
MCF10A cells over 48 hours from oncogene induction. (B) Representative confocal images showing the distribution of E-cadherin at t = 0 hours and within nontrans-
formed and HRAS-transformed tissues at t = 24 hours. E-cadherin is labeled in gray, nuclei are labeled in blue. Scale bars, 50 m. (C and D) Global E-cadherin fluorescence 
intensity in non-transformed (control) and HRAS-transformed epithelia: (C) junctional intensity (normalized) and (D) ratio of junctional to cytoplasmic intensity. Means ± SEM 
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decrease in cell-matrix adhesion followed by an increase in active 
epithelial tension, as observed experimentally (Figs. 4G and 5, 
C and F), is sufficient to emulate epithelial bilayer’s retraction and 
the oscillation of the traction force magnitude to the extents observed 
in vitro (Figs. 1E and 2, K and L). Our simulations show that the 
reduction in cell-matrix adhesion alone could only account for a 
monotonical reduction in traction-force magnitude (Fig. 6L), whereas 
the increase in cell-cell tension alone could only lead to a monotonical 
increase of traction-force magnitude (Fig.  6M) and decrease in 
epithelial area (Fig. 6L).
As a further experimental test of this idea, in experiments, we 
interfered with the build-up of epithelial tension at 6 hours (earlier 
stage; Fig.  7,  B,  C,  F,  and  G) and at 24 hours (later stage; 
Fig. 7, D, E, H, and I) following RAS induction using pharmaceutical 
treatments that reduce epithelial tension. The inhibition of 
ROCK (Y27632; Fig. 7, A and B) or myosin II (blebbistatin; Fig. 7, 
A and C) at 6 hours prevented traction forces from recovering to 
pretransformation levels (Fig. 7F), preventing the contraction of 
epithelial monolayer (Fig. 7G). Similarly, the inhibition of ROCK 
(Y27632; Fig. 7, A and B) or myosin II (blebbistatin; Fig. 7, A and C) 
at 24 hours caused a drop in increasing traction forces (Fig. 7H) 
and prevented the morphological dewetting of the RAS-transformed 
bilayers at later time points (Fig. 7I). Hence, reduction of epithelial 
tension through ROCK or myosin II inhibition restored the 
mechanical stability of RAS-transformed epithelia within the time 







Fig. 5. Oncogenic HRAS induction causes a tension differential in the MCF10A bilayers. Representative confocal images of nontransformed monolayer (A) and 
HRAS-transformed bilayer (D) at t = 24 hours from oncogene induction stained for pMLC2, F-actin, and DAPI (nuclei, shades of grays). Focal planes are orthogonal to the 
substrate matrix. Scale bar, 20 m. (B, E, and G) Representative confocal images of entire nontransformed monolayer (B) and HRAS-transformed bilayer [(E) bottom layer 
and (G) top layer of the bilayer]. Focal plane crosses the tissue parallel to the substrate matrix. pMLC2, F-actin, and DAPI (nuclei) are labeled either in color code (red, gray, 
and blue, respectively) or shades of grays. Scale bars, 50 m. (C) Relative fold change in averaged global intensity relative to center of the monolayer of pMLC2 fluorescence 
from edge to edge of the circular epithelial domain of nontransformed (blue) and HRAS-transformed (pink) monolayers (n = 3 and means ± S.D. in blue). (F) Relative fold 
change in averaged global intensity relative to center of the monolayer of F-actin fluorescence from edge to edge of the circular epithelial domain of nontransformed 
(blue) and transformed (pink) monolayers (n = 3 and mean ± S.D. in blue) and (H) individual averaged intensity profiles of pMLC2 (red) and F-actin (gray) of a representative 
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Fig. 6. In silico model of HRAS-driven mechanical instability in MCF10A circular tissues. (A and B) Schematic of experimental features captured and emulated by the 
computational model (Materials and Methods). (A) Epithelium as a 2D continuum (grays) having bulk stiffness E, Poisson ratio , and finite thickness in plane-stress 
approximation. (B) Inter- and intracellular forces along with cell-matrix forces at the interface with the elastic substrate. Epithelium is uniformly subjected to a contractile 
prestrain constant in time (green arrows). Epithelial subdomain 2 (light gray) can further develop active strain. Active strain and prestrain develop contractile tensions 
equilibrating passive elastic forces within the epithelium and result in traction forces (magenta arrows) on the substrate matrix via solid viscoelastic friction (wavy blue 
elements). (C) Finite element discretization of the 2D epithelium. A representative finite element is highlighted. (D) Decomposition of forces acting at nodes of a representative 
finite element. (E) Epithelial contractile tension in epithelial subdomain 2 (orange) increases from baseline pretransformation levels of epithelial subdomain 1 (green) 
due to the combined effects of active strain and prestrain. (F) Adhesion with the substrate monotonically decreases from pretransformation levels in 1 and 2. (G) Evolution 
of epithelial tension (orange), active strain (gray), and prestrain (green). (H to M) Graphs comparing evolution of epithelial features in vivo (gray shaded lines) and in silico 
(i.e., model’s predictions). All trends have been normalized to time point t = −4 hours. (H, J, and K) Normalized epithelial surface area in silico (black line). (I, L, and M) 
Normalized traction force magnitude in silico (magenta line). (H and I) Case of both tension increase at the epithelium’s periphery and adhesion decrease throughout the 
epithelium. (J and L) Case of only adhesion decrease throughout the epithelium (no tension increase at the epithelium’s periphery). (K and M) Case of only tension increase 
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Together, our simulations and experiments suggested that RAS 
transformation induced a state of mechanical instability in epithelia 
during the first 24 hours of oncogene induction, where increased cell-cell 
tension is unbalanced by decreased cell-matrix adhesion. As a result, 
the homeostatic equilibrium of the RAS-transformed bilayers is lost, 
and this sets the bilayers on a path to a 3D morphological transformation.
DISCUSSION
The RAS-genes superfamily functions as a crucial signaling hub within 
the cell, which controls several of its critical signaling cascades. This also 
reflects how profoundly the abnormal activity of RAS affects human 
development and disease (7, 8, 45). RAS mutations alter the morphology 
and mechanics of individual cells (46). In addition, as we show here, 
these morphomechanical changes are integrated at the tissue scale to 
induce profound changes in the organization of epithelia (Fig. 1). Thus, 
that uniform RAS induction induces changes in cellular morphologies 
and forces (Figs. 1 and 2), leading to the formation and contraction of 
a complex 3D cellular architecture via active dewetting (fig. S1).
This morphomechanical transformation is mediated by a series 
of changes in epithelial architecture and mechanics that are induced 
during the first 24 hours of uniform HRAS-oncogene induction 
(Fig. 3). These include (i) the establishment of two layers of cells 









Fig. 7. Targeting epithelial tension during HRAS transformation. (A) Schematic of the action of inhibitors. (B to E) Representative phase contrast images of confined 
nontransformed (Control) and HRAS-transformed MCF10A epithelia treated with ROCK inhibitor Y27632 (10 Μ) (B and D) or myosin II inhibitor blebbistatin (25 Μ) 
(C and E) during early transformation (6 hours) (B and C) or late transformation (24 hours) (D and E) Scale bars, 100 m. (F and H) Time evolution of normal components of the 
traction-force field in the outer epithelial subdomains during early (F) and late (H) transformation in the presence of inhibitors. (G and I) Time evolution of the surface area of 
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high E-cadherin cell-cell junctions in the top layer and low E-cadherin 
cell-cell junctions in the bottom layer (Fig. 4); (ii) local reductions 
in cellular adhesion to the substrate (fig. S7), leading to decreased 
traction forces transferred by the affected tissues to the substrate (Fig. 2); 
and (iii) a redistribution of regulators of cellular tension (F-actin and 
pMLC2), which become concentrated at the periphery of the bilayer 
(Fig. 5). Our report of increased differential tension with reduction 
in adhesion during early oncogenic transformation contrasts the reports 
for fully malignant phenotypes, where increases in tension correlate 
with increases in focal adhesion formation (47). This highlights im-
portant differences between early and late malignant phenotypes. In 
the future, it will be fascinating to assess how the local changes in 
cell biology are induced by the uniform expression of oncogenic 
RAS. Our analysis shows how these local heterogeneities, when 
combined, give rise to the change in overall tissue organization 
and mechanics.
In a previous study, overexpression of E-cadherin in cancer cells 
set the epithelial monolayer for active dewetting (36). Here, we 
show that HRAS drives a decrease in cell-matrix adhesion and the 
redistribution of main regulators of epithelial tension, such as (i) 
F-actin and pMLC2, which became concentrated at the periphery of 
the bilayer (Fig. 5, C and F), and (ii) E-cadherin, which became 
differentially distributed between the top and bottom layers of the 
bilayer (Fig. 4). Our computational simulations show that this 
imbalance in cell-cell tension and cell-matrix adhesion brought about 
by oncogenic RAS expression is sufficient to place RAS-transformed 
epithelia into a state of mechanical instability (Fig. 6), which primes 
them for active dewetting (Fig. 1). Actively reducing tension through 
ROCK or myosin II inhibition further validated the role of the 
mechanical instability in this morphomechanical process.
Together, our findings demonstrate how activation of RAS 
oncogenes, even over short time periods, induces a mechanical 
imbalance in epithelial monolayers that results in the loss of homeo-
stasis and a marked morphological transformation mimicking those 
seen in RAS-mutant human tumors. In pancreatic cancer, a me-
chanical imbalance following the oncogenic KRAS expression similar 
to the one studied here drives the pathological morphing of the 
pancreatic duct (24). Furthermore, increases in actomyosin tension 
in pancreatic ductal carcinoma also correlate with increased ECM 
remodeling and fibrosis (48), which are critical for oncogenic signaling 
to promote tumorigenesis (49). In squamous cell carcinoma, HRAS 
activation leads to layering via the loss of tissue polarity and organi-
zation (50). Here, we show that RAS-driven formation of two tissue 
layers with very different adhesive and contractile properties is a key 
event in the disruption of homeostatic equilibrium. By establishing 
a mechanical imbalance through RAS-transformed tissues, epithelial 
bilayering may also provide a favorable intermediate mechanism to 
abnormally morph epithelia without the need for an extended in-
terface with nontransformed tissues (19, 22–24, 50). Overall, our 
findings establish a new physical mechanism of cellular collectives 
through which RAS can regulate the pathological morphology of 
epithelia autonomously of cell competition.
MATERIALS AND METHODS
Experimental design
To study mechanics in epithelial monolayers, we cultured epithelial 
cells on micropatterned PAA gels of defined stiffness (12 kPa). 
Detailed steps are described below.
MCF10A cell culture
Immortalized epithelial breast cell line MCF10A was transfected 
with inducible 12V-mutated form of the HRAS gene (a gift from 
Julian Downwards laboratory, University College London, London, 
UK) (25), referred to as MCF10A/ER.HRAS V12. They were main-
tained in complete medium composed of phenol-free Dulbecco’s 
modified Eagle’s medium (DMEM)–F12 medium (Thermo Fisher 
Scientific, #11039047) supplemented with 5% charcoal-stripped horse 
serum (Thermo Fisher Scientific, #16050122), penicillin (100 U/ml) 
and streptomycin (100 g/ml; Thermo Fisher Scientific, #15070), 
epidermal growth factor (20 ng/ml; PeproTech, #AF100-15), hydro-
cortisone (0.5 mg/ml; Sigma-Aldrich, #H0888), cholera toxin 
(100 ng/ml; Sigma-Aldrich, #C8052), and insulin (10 g/ml; Sigma- 
Aldrich, #I1882) (51) at 37°C in a humidified incubator with 5% 
CO2. Confluent cells were passaged every 2 or 3 days at 1:4 dilution.
Polyacrylamide (PAA) gel substrates
Glass-bottom six-well dishes (#0 thickness; IBL, #220.200.020) were 
treated with a Bind-Silane solution consisting of PlusOne Bind-Silane 
(VWR, #17-1330-01) and acetic acid (Panreac Quimica, #131008-
1612) in absolute ethanol for 1 hour at room temperature (RT) in a 
fume hood. Wells were washed three time with ethanol and dried. 
PAA gels with a Young’s modulus of 12 kPa were prepared by mixing 
18.8% of 40% (w/v) acrylamide (Bio-Rad, #1610140), 8% of 2% (w/v) 
bis-acrylamide (Bio-Rad, #1610142), 0.5% of 10% ammonium persulfate 
(Bio-Rad, #161-0700), 0.05% of N,N,N,N′-tetramethylethylenediamine 
(Sigma-Aldrich, #T9281), and 0.7% of FluoSpheres carboxylate 
modified microspheres (0.2 m, dark red; Thermo Fisher Scientific, 
#F8807) in Hepes solution (Thermo Fisher Scientific, #15630056). 
Twenty-two microliters of solution was placed on the treated glass 
well and covered with an 18-mm-diameter coverslip. After 1-hour 
polymerization at RT, phosphate-buffered saline (PBS) was added 
to the wells and coverslips were carefully removed. Gels were 
washed with PBS.
Polydimethylsiloxane (PDMS) membranes
SU8-50 master containing circular patterns with diameter of 400 m 
and height of 50 m was prepared using conventional photolithog-
raphy. Polydimethylsiloxane (PDMS) was spin-coated on the masters 
to a thickness lower than the height of the SU8 features (15 m) and 
cured overnight at 85°C. A thick border of PDMS was left at the 
edges of the membranes for the handling purpose. PDMS membranes 
were peeled off and kept at 4°C until use.
Collagen patterning
To pattern collagen on top of PAA gels, gels were functionalized 
with a solution of Sulfo-SANPAH [1 mg/ml; sulfosuccinimidyl 
6-(4′-azido-2′-nitrophenylamino) hexanoate; Thermo Fisher Scientific, 
#22589] for 5 min under ultraviolet lamp (XX-15, UVP) under 
365-nm wavelength. After washing off remaining Sulfo-SANPAH 
with sterile PBS, gels were left to air-dry for 20 min inside a cell 
culture hood. PDMS membranes (nine patterns per membrane), 
passivated in 2% Pluronic F-127 (Sigma-Aldrich, #P2443) in ddH2O 
for at least 24 hours, were washed in PBS and air-dried inside a cell 
culture hood. PDMS membranes were placed on top of the PAA 
gels, and 50 l of rat tail collagen type I solution (0.1 mg/ml; First 
Link, #112296) was placed on top of the patterns. PAA gels were 
incubated overnight at 4°C.
Monolayer patterning
PDMS membranes were removed from the top of the PAA gels by 
first adding sterile PBS. Gels were washed with PBS and incubated 
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SUSOS AG] for 30 min at 37°C. In the meantime, MCF10A cells 
were trypsinized and counted. Following incubation, gels were 
washed once with PBS and air-dried for 5 min. MCF10A cell 
suspension (50 l) containing 50,000 cells was placed on top of the 
gel. Cells were incubated for 1 hour for attachment; the non-attached 
cells were washed three times with PBS, and cells were incubated in 
DMEM-F12 media for 24 hours in 5% CO2 at 37°C.
Drug treatment
After 24 hours of incubation, supernatant was aspirated and fresh 
DMEM-F12 medium containing 4-OHT (100 nM; Sigma-Aldrich, 
#H7904) was added to conditionally express HRAS, while equiva-
lent amount of vehicle control, DMSO (1:1000, control), was added 
to control wells. For proliferation inhibition a cyclin-dependent ki-
nase 1 inhibitor RO-3306 (Sigma-Aldrich, #SML0569) was used at 
9 M at the same time as 4-OHT/DMSO treatment and throughout 
the imaging. To inhibit epithelial tension, 10 M ROCK inhibitor 
Y27632 (Sigma-Aldrich, #Y0503) or 25 M myosin II inhibitor 
(±)-blebbistatin (Sigma-Aldrich, #203390) was added to media after 
6 or 24 hours of HRAS induction (with 4-OHT still present throughout 
the experiments).
Western blot
To confirm HRAS induction with 4-OHT, total cell protein lysates 
were obtained by lysing cells exposed to 100 nM 4-OHT with radio- 
immunoprecipitation assay (RIPA) buffer (Thermo Fisher Scientific, 
#89900) containing phosphatase inhibitor cocktail 1 and 2 (Sigma- 
Aldrich, P5726 and P2850) and protease inhibitor cocktail (Sigma- 
Aldrich, #11836170001). Protein content was quantified with BCA 
Protein Assay kit according to the manufacturer’s instructions 
(Thermo Fisher Scientific, #23227), and 20 g of protein was mixed 
with 2× Laemmli buffer (Sigma-Aldrich, #S3401) and boiled for 
5 min at 95°C. Protein were separated using MOPS buffer (Thermo 
Fisher Scientific, #NP0001) in NuPAGE 4 to 12% bis-tris protein 
gels (Thermo Fisher Scientific, #NP0323BOX) at 150 V for 70 min 
at RT. Proteins were transferred to a nitrocellulose membrane at 
100 V for 60 min at 4°C. Membranes were blocked for 30 min in 5% 
milk in tris-buffered saline with Tween 20 (TBST), followed by 
overnight incubation with primary antibodies diluted in 2.5% milk 
in TBST. Primary antibodies included rabbit phospho p44/42 
mitogen-activated protein kinase (MAPK) (ERK1/2) (1:2000; Cell 
Signaling Technology, #4370S), rabbit p44/42 MAPK (Erk1/2) 
(1:2000; Cell Signaling Technology, #4695S), and mouse E-cadherin 
(1:1000; BD Biosciences, #610181). Primary antibodies were washed 
three times with TBST, followed by 1-hour incubation with second-
ary antibodies diluted in 2.5% milk in TBST [1:5000; goat anti- 
rabbit horseradish peroxidase (HRP) or goat anti-mouse HRP; 
DAKO, #P0448 and #P0447]. Membranes were washed three times 
with TBST and exposed to HRP substrate (Immobilon Crescendo, 
Millipore, #WBLUR0100) for chemiluminescence detection using 
ChemiDoc MP Imaging System (Bio-Rad).
Time-lapse microscopy
Multidimensional acquisitions were performed on an automated 
inverted microscope (Nikon Ti2 Eclipse, Nikon) using 20× objective 
(Nikon CFI Plan Apo 20X/0.75 Ph DM). Microscope was equipped 
with thermal, CO2, and humidity control and controlled using NIS 
software and perfect focus system. Images were obtained every 
15 min over 50 hours. Up to 15 independent patterns were imaged 
in parallel using a motorized XY stage. Patterns where cells 
formed full monolayers at the start of experiments were selected 
for imaging.
Traction force microscopy
Gel displacements between any experimental time point and a 
reference image obtained after cell trypsinization were computed 
by using a custom-made particle imaging velocimetry code developed 
in the laboratory of X. Trepat by using 32-pixel resolution and overlap 
of 0.5. Traction forces were computed from hydrogel displacements 
through a custom-made code, which is based on a Fourier trans-
form algorithm for elastic hydrogel substrates having finite thick-
ness (52). Patterns for analysis were selected on the basis of quality 
of bead images, remained in focus throughout the imaging. To 
define the outer and inner domain, the binary mask of epithelia 
(identified by filling in their contour) was divided into concentric 
rings that are one single pixel in thickness. Rings are then labeled 
through integers 1 to n moving from the edge of the pattern toward 
its center. The external and internal subdomains are identified by 
grouping adjacent rings together; the first m rings from the edge 
(labels 1 to m) are merged to form the external subdomain, whereas 
the remaining n-m rings are merged to form the inner subdomain 
(the core of the disk). The label m is determined in such a way that 
both domains contain the same amount of pixels/data for unbiased 
statistical analyses over the two subdomains. The algorithm 
was implemented in MATLAB (license number 284992) for 
automatic execution on the individual mask of epithelia at each 
time point.
Monolayer stress microscopy
Intercellular and intracellular stresses in nontransformed MCF10A 
monolayers were computed via monolayer stress microscopy (30) 
via a custom software implemented via the custom finite element 
method platform EMBRYO developed in the laboratory of J.J. Muñoz. 
Briefly, the forces exerted by the elastic hydrogel substrate on the 
MCF10A epithelium (as a reaction to the traction force field trans-
ferred by the epithelium to the substrate) are equilibrated by the 
tensorial stress state within the epithelium. A necessary condition 
for the application of this technique is that epithelia maintain their 
monolayer architecture, a hypothesis only valid for nontransformed 
MCF10A monolayers in this study.
Immunofluorescence
Cells were fixed with 4% paraformaldehyde (Santa Cruz Biotechnology, 
#sc-281692) for 10 min and washed with PBS. Samples were incu-
bated with block buffer containing 1% bovine serum albumin 
(Sigma-Aldrich, #A7906) and 0.3% Triton X-100 (Sigma-Aldrich, 
#T8787) in PBS at RT for 1 hour. Primary antibodies (mouse E-cadherin, 
1:1500; BD Biosciences, #610181; mouse integrin 1, 1:250; 
Abcam, ab30394; rabbit pMLC2, 1:50; Cell Signaling Technology, 
#3671S; mouse integrin 3, 1:200; Merck, #MAB2023Z; mouse 
anti-CD61 (integrin 3), 1:200; eBioscience, #16-0611-82; mouse 
integrin V6, 1:200; Merck, #MAB2077Z) were diluted in block buffer 
and incubated on top of samples overnight at 4°C. Subsequently, 
samples were incubated with secondary antibodies (fluorescein 
isothiocyanate (FITC) anti-mouse, 1:1000; Jackson ImmunoResearch, 
#715-545-150; Alexa Fluor 564 anti-rabbit, 1:500; Thermo Fisher 
Scientific, #A11035) for 2 hours at RT. F-actin was stained by incu-
bating for 30 min with phalloidin-iFluor 594 CytoPainter (1:2000; 
Abcam, #ab176757) or Phalloidin-Atto 647N (1:1000; Sigma-Aldrich, 
#65906) at RT. In between steps, samples were washed with wash 
buffer [0.05% Tween 20 (Sigma-Aldrich, #P9416) in PBS]. Samples 
were covered with Fluoroshield mounting medium containing 
4′,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich, #F6057) and 
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Microscopy
Fluorescent images of the patterns were acquired with an inverted 
microscope (Nikon Ti2 Eclipse, Nikon) with an objective 20×/0.75 
(Nikon CFI Plan Apo 20X/0.75 Ph DM). Confocal images were 
taken using inverted confocal microscope Axio Observer 7 (Spectral 
Detection Zeiss LSM 800) using 40×/1.3 Oil DIC M27 or 63×/1.4 
Oil DIC M27 objectives with ZEN 2.3 imaging software. For 
integrin imaging, Zeiss Axiovert 200M microscope was used with 
20× and 40× objective. For pMLC2 imaging, Zeiss LSM 780 micro-
scope was used with 20×/0.8 M27 Plan-Apochromat and 40×/1.20 W 
Korr M27 C-Apochromat objectives using ZEN 2.1 SP3 software.
Nanoindentation
Monolayer stiffness (Young’s modulus) was measured by means of 
the Piuma Nanoindenter (from Optics 11) fitted with a cantilever 
having stiffness of 0.05 N/m and spherical tip with a radius of 10 m. 
Four measurements were taken from three different samples. The 
Young’s modulus of epithelia before oncogene induction resulted 
in 1.363 ± 0.504 kPa (mean ± SD).
Image analysis
To detect the physical properties of the epithelial monolayer from 
fluorescent images, a pipeline was created in CellProfiler (53) and 
followed by postprocessing of the images and data in custom-made 
automatic workflow in MATLAB (license number 284992). Images 
of nuclei and F-actin were used to detect both the individual nuclei 
and cell borders within monolayers. The intensity of the images was 
rescaled to the full range of the intensity histograms (minimum, 0; 
maximum, 1), and uneven illumination was corrected by subtract-
ing a spline illumination function. Nuclei were segmented using the 
adaptive Otsu three-class thresholding with the middle intensity 
class assigned as the background. To improve detection, we opti-
mized minimum diameter (16-pixel unit) and threshold correction 
factor (0.8). Clumped objects were distinguished by intensity and 
cell outlines by propagation method. The precision of nuclei detec-
tion was assessed by comparing the outcomes of the pipeline with 
manual nuclei detection in ImageJ. Features extracted from the image 
processing included cell ID, nuclei center coordinates, areas, and perim-
eters. Using custom-made workflow in MATLAB (license number 
284992), we calculated cell and nuclei shape indices and removed 
outliers (based on surface areas, shape index, and nucleus areas).
E-cadherin analysis
To measure E-cadherin intensity, a line was drawn using Fiji ImageJ 
(version 1.53c) (54) between two nuclei. The intensity range was 
then normalized by subtracting the 1st percentile and dividing by 
99th percentile. The junctional intensity was extracted, and the 
ratio between junctional and cytoplasmic intensity was calculated 
by dividing the junctional value by average of the cytoplasmic value.
Integrin analysis
To measure integrin intensity, a global intensity value of the total 
image was obtained with ImageJ.
pMLC2 analysis
Fluorescence intensity was determined using Fiji. Rectangular shape 
(531.37 m by 290 m) was placed from one end of the image to 
other encompassing the middle part of the pattern, and the average 
intensity was measured. The background intensity was removed by 
calculating intensity in area outside the pattern for each image. Data 
from three independent patterns were presented as means ± SE.
Data analysis
To perform statistical analysis, GraphPad Prism (version 9.0.0) was 
used. Data distribution was assessed using D’Agostino and Pearson 
omnibus normality test. Data from all conditions had to pass the 
normality test to be included in parametric testing: for nonparametric 
data, (i) two groups, Mann-Whitney U test; (ii) more than two 
groups, Kruskal-Wallis statistic test used with Dunn’s multiple 
comparison test; (iii) two groups over long time course, two-way 
analysis of variance (ANOVA) with Bonferroni post-test; and (iv) 
one condition over long time course, Friedman test with Dunn’s 
multiple comparison test. P < 0.5 indicated a statistical significance 
(*P < 0.05, **P < 0.01, and ***P < 0.001).
Computational model
The evolution of the net radial traction components is modeled by 
resorting to a 2D finite element model of the flat tissue. The flat 
tissue is represented by a circular domain  with radius R with two 
distinct subdomains: subdomain 1 subjected to a constant base-
line contractile force   0 
c (prestrain) and subdomain 2 subjected to 
an additional active contractile strain c for a total contractile strain 
of   =   0 
c +   c (Fig. 6B). The radius of the central subdomain 1 
decreases in time from R (pretransformation levels) to  r =  R ⁄ 3 to 
emulate the shape of the pMLC2 trend (Fig. 5C). The underlaying 
substrate is modeled as a set of nodal locations fixed in time. The 
elastic domains 1 and 2 develop local tension because of these 
prescribed strains. Moreover, each domain is subjected to a specific 
degree of a solid viscoelastic adhesion with the underlying substrate 
(44), which is specifically modeled via a Kelvin-Voight model. 
Weakening of cell-matrix adhesion is simulated by applying a re-
duction factor  to the cell-matrix adhesion constant . The subdo-
mains 1 and 2 are assumed to have linear elastic behavior, and 
tissue motion is determined in the approximation of quasi-static 
equilibrium; there, the active contractility c and the baseline pre-
strain   0 
c equilibrate the passive elastic forces within the tissue and 
the adhesion forces with the substrate. Model’s deformations in 
each subdomain 1 and 2 were determined via Cauchy’s equation
  ∇ ·  + f = 0 (1)
where  is the elastic stress tensor given by  =  trace(e) + 2e, 
e is the elastic strain, with   e =  −   0  
c I in 1 and   e =  − (  0 
c +   c ) I 
in 2,  = E/((1 + )(1 − 2)) and  = E/(2(1 + )) are the Lamé 
elasticity constants, E is the Young modulus and  the Poisson ratio 
of both subdomains 1 and 2, f = ku is the adhesion force 
between the tissue and the substrate, u is the tissue displacement 
and ui is its component, ij= 0.5(∂iuj + ∂jui) is the total (observable) 
strain, and  is the weakening factor of the tissue adhesion forces 
with the substrate.
We use the finite element method to turn Eq. 1 into a linear 
system of equations
  (K +  K s ) u = f (2)
where K and Ks are the stiffness matrices corresponding to the elas-
tic and adhesive contributions, respectively.
The force vector f in Eq. 2 represents the resulting contractile 
force due to active contractile strain c and/or baseline prestrain   0 
c . 
The time evolution of , c, and   0 
c are given in table S1. Vector f 
includes the assembling of vectoral contributions f1 and f2, respec-
tively, from the subdomains 1 and 2, with
 f 1 =   0 
c ∫ 
  1 
  B T D  {1 1 0} T  d and  f 2 = (  0 
c +   c )  ∫ 
  2 
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where B is the deformation matrix such that  = Bu and D is the 
elasticity matrix that depends on E and .
Last, the discretization of the finite element mesh used 7860 
square elements (100 elements along the diameter). We then used 
experimental data to set (i) the bulk stiffness of the epithelium as 
having a value of 1 kPa before HRAS activation; this is based on 
nanoindentation measurements of MCF10A epithelia having an 
in vitro stiffness of 1.36 ±0.5 kPa (see Materials and Methods). 
Furthermore, for the sake of simplicity, we also set (ii) the Poisson’s 
Ratio of the tissue elasticity to  = 0.46 (quasi-incompressibility), 
(iii) the drop in adhesion with the substrate to a monotonic 
decrease (Fig. 6, B and F) emulating the average drop in the expression 
of the collagen receptor integrin 1 within 24 hours from RAS acti-
vation (fig. S7, B and C), and (iv) a linear increase in local contrac-
tile strain   =   0 
c +   c (Fig. 6, B and G) to a value approximately 
double that of the homeostatic baseline; this is based on combined 
pMLC2 fluorescence intensity from bottom and top layers of the 
RAS-transformed bilayer (Fig.  5,  F  and  H) that approximately 
amounts to double that of nontransformed monolayers (Fig. 5C). 
All model’s parameters are summarized in table S1.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at https://science.org/doi/10.1126/
sciadv.abg6467
View/request a protocol for this paper from Bio-protocol.
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